AU2003252164A8 - Insulin-producing cell compositions and related methods - Google Patents

Insulin-producing cell compositions and related methods

Info

Publication number: AU2003252164A8
Authority: AU; Australia
Prior art keywords: insulin; related methods; producing cell; cell compositions; compositions
Prior art date: 2002-07-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003252164A

Other versions

AU2003252164A1 (en

Inventor

Ingrid Rulifson

Yuichi Hori

Seung Kim

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Leland Stanford Junior University

Original Assignee

Leland Stanford Junior University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-25

Filing date

2003-07-25

Publication date

2004-02-16

2003-07-25 Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University

2004-02-16 Publication of AU2003252164A1 publication Critical patent/AU2003252164A1/en

2004-02-16 Publication of AU2003252164A8 publication Critical patent/AU2003252164A8/en

Status Abandoned legal-status Critical Current

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
229940125396 insulin Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/22—Coculture with; Conditioned medium produced by pancreatic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Cell Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AU2003252164A 2002-07-25 2003-07-25 Insulin-producing cell compositions and related methods Abandoned AU2003252164A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US39893902P	2002-07-25	2002-07-25
US60/398,939		2002-07-25
US42663202P	2002-11-14	2002-11-14
US60/426,632		2002-11-14
PCT/US2003/023346 WO2004010933A2 (en)	2002-07-25	2003-07-25	Insulin-producing cell compositions and related methods

Publications (2)

Publication Number	Publication Date
AU2003252164A1 AU2003252164A1 (en)	2004-02-16
AU2003252164A8 true AU2003252164A8 (en)	2004-02-16

Family

ID=31191239

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003252164A Abandoned AU2003252164A1 (en)	2002-07-25	2003-07-25	Insulin-producing cell compositions and related methods

Country Status (2)

Country	Link
AU (1)	AU2003252164A1 (en)
WO (1)	WO2004010933A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2753309B1 (en)	2011-09-08	2020-01-01	Hexal AG	Pharmaceutical compound for oral administration with a statin
ES2840076T3 (en)	2015-04-24	2021-07-06	Univ Copenhagen	Isolation of pancreatic progenitor cells bona fide
CA2983845C (en)	2017-10-26	2024-01-30	University Of Copenhagen	Generation of glucose-responsive beta cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6165733A (en) *	1996-05-23	2000-12-26	Chiron Corporation	γ II adaptin
US6242666B1 (en) *	1998-12-16	2001-06-05	The Scripps Research Institute	Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells

2003
- 2003-07-25 WO PCT/US2003/023346 patent/WO2004010933A2/en not_active Ceased
- 2003-07-25 AU AU2003252164A patent/AU2003252164A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004010933A2 (en)	2004-02-05
AU2003252164A1 (en)	2004-02-16
WO2004010933A3 (en)	2004-11-11

Publication	Publication Date	Title
EP1545457A4 (en)	2009-07-01	Cell transport compositions and uses thereof
AU2003220205A8 (en)	2003-09-29	Ethanol-diesel fuel composition and methods thereof
GB0411940D0 (en)	2004-06-30	Methods and compositions
EP1701725A4 (en)	2009-07-01	Methods and compositions
AU2003262747A8 (en)	2004-03-11	Compounds, compositions, and methods
EP1503993A4 (en)	2006-05-03	Compounds, methods and compositions
AU2003236527A8 (en)	2003-12-31	Compounds, compositions, and methods
AU2003265242A8 (en)	2003-12-22	Compounds, compositions, and methods
AU2003270015A8 (en)	2003-12-02	Compounds, compositions, and methods
AU2003299612A8 (en)	2004-07-09	Compounds, compositions and methods
AU2003241313A8 (en)	2003-11-10	Compositions and methods for stem cell delivery
AU2003256805A8 (en)	2004-02-09	Compounds compositions and methods
AU2003277079A8 (en)	2004-05-04	Compounds, compositions, and methods
GB0202059D0 (en)	2002-03-13	Chemical compositions and methods
AU2003290507A8 (en)	2004-04-08	Compounds, compositions and methods
AU2003266282A8 (en)	2004-02-23	Compositions comprising muscle progenitor cells and uses thereof
AU2003240281A8 (en)	2003-12-31	Cell targeting methods and compositions
AU2003300031A8 (en)	2004-05-04	Compounds, compositions, and methods
AU2003267169A8 (en)	2004-04-30	Compounds, compositions and methods
AU2003268078A8 (en)	2004-02-25	Levothyroxine compositions and methods
AU2003252164A8 (en)	2004-02-16	Insulin-producing cell compositions and related methods
AU2003275240A8 (en)	2004-04-23	Methods and compositions for soluble cpg15
GB0207224D0 (en)	2002-05-08	Tenascin-W compositions and uses thereof
AU2003245524A8 (en)	2003-12-31	Cryosurgery compositions and methods
GB0325942D0 (en)	2003-12-10	Compositions and uses thereof